Sobi Nominates Ex-Ericsson CEO Börje Ekholm as Board Chair
STOCKHOLM – October 30, 2026 -- The Nomination Committee of Swedish Orphan Biovitrum AB (Sobi) proposes Börje Ekholm, who recently stepped down as CEO of Ericsson, as new Board member and Chair at the 2027 Annual General Meeting (AGM). He would succeed David Meek, who has told the committee he will not stand for re-election.
Meek stays on as Chair until May 2027
Meek has served on Sobi's Board and as Chair since December 2024 and will remain Chair for the rest of his term, which runs to May 2027. The committee credits his tenure with strong growth and shareholder return, wider patient access through new launches and indication extensions, and a stronger clinical development pipeline.